Chagas Disease Prevalence in a Cohort of Neurocysticercosis Patients in a Nonendemic Setting
- PMID: 35134144
- PMCID: PMC9477447
- DOI: 10.1093/cid/ciac076
Chagas Disease Prevalence in a Cohort of Neurocysticercosis Patients in a Nonendemic Setting
Abstract
In a cohort of mostly Central American immigrants with confirmed neurocysticercosis (NCC), 3.1% were confirmed positive for Chagas disease (CD). The majority were diagnosed with NCC before age 50. Entry to care for NCC is an opportunity for early detection and possible treatment for CD in those from endemic areas.
Keywords: Chagas disease; neurocysticercosis; screening.
Published by Oxford University Press for the Infectious Diseases Society of America 2022.
Conflict of interest statement
Potential conflicts of interest. L. T. reports being past president (volunteer, unpaid) of the Pennsylvania State University, College of Nursing Alumni Society. All other authors report no potential conflicts. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.
References
-
- World Health Organization. Chagas disease in Latin America: an epidemiological update based on 2010 estimates. Wkly Epidemiol Rec 2015; 90:33–43. - PubMed
